;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Mapi-Pharma amends IPO

    Mapi-Pharma Ltd., Ness Ziona, Israel Business: Drug delivery, Generics Date announced: 4/17/14 Type: IPO To be raised: Up to $42.9 million Shares: 2.9 million Price: $13-$15 Underwriter: Aegis Capital Overallotment: 428…

    Published on 4/21/2014
  • Microlin Bio amends IPO

    Microlin Bio Inc., New York, N.Y. Business: Cancer Date announced: 4/16/14 Type: IPO To be raised: Up to $32.7 million Shares: 2.7 million Price: $10-$12 Underwriters: Brean Capital; Summer Street Overallotment: 409,091…

    Published on 4/21/2014
  • Quotient amends IPO

    Quotient Ltd., Penicuik, U.K. Business: Diagnostic Date announced: 4/14/14 Type: IPO To be raised: Up to $55 million Shares: 5 million Price: $9-$11 Underwriters: UBS; Baird; Cowen Overallotment: 750,000 Note: Quotient …

    Published on 4/21/2014
  • AAVLife completes venture financing

    AAVLife, Paris, France Business: Neurology, Gene/Cell therapy Date completed: 4/15/14 Type: Venture financing Raised: $12 million Investors: Versant Ventures; Inserm Transfert Initiative

    Published on 4/21/2014
  • Antibe Therapeutics completes private placement

    Antibe Therapeutics Inc. (TSX-V:ATE), Hamilton, Ontario Business: Inflammation, Neurology, Autoimmune Date completed: 4/7/14 Type: Private placement Raised: C$909,960 ($829,429) Shares: 1.5 million Price: C$0.60 Shares …

    Published on 4/21/2014
  • Benitec completes private placement

    Benitec Biopharma Ltd. (ASX:BLT), Sydney, Australia Business: Functional genomics, Proteomics Date completed: 4/15/14 Type: Private placement Raised: A$15.7 million ($14.8 million) Shares: 14.7 million Price: A$1.07 …

    Published on 4/21/2014
  • Cel-Sci completes follow-on

    Cel-Sci Corp. (NYSE-M:CVM), Vienna, Va. Business: Cancer, Infectious Date completed: 4/17/14 Type: Follow-on Raised: $10 million Units: 7.1 million Price: $1.40 (unit) Shares after offering: 65.4 million Underwriters: …

    Published on 4/21/2014
  • Cynapsus completes private placement of units

    Cynapsus Therapeutics Inc. (TSX:CTH), Toronto, Ontario Business: Drug delivery, Neurology Date completed: 4/15/14 Type: Private placement of units Raised: C$25 million ($22.8 million) Units: 38.5 million Price: $0.65 (…

    Published on 4/21/2014
  • Epirus completes venture financing

    Epirus Biopharmaceuticals Inc., Boston, Mass. Business: Biosimilars, Autoimmune, Antibodies Date completed: 4/16/14 Type: Venture financing Raised: $36 million Investors: Livzon Mabpharm; Adage Capital Management; …

    Published on 4/21/2014
  • Eventus Diagnostics completes venture financing

    Eventus Diagnostics Inc., Miami, Fla. Business: Diagnostic, Cancer Date completed: 4/15/14 Type: Venture financing Raised: $2.7 million Investors: Private investor; existing investors

    Published on 4/21/2014
  • ForSight Vision5 completes venture financing

    ForSight Vision5 Inc., Menlo Park, Calif. Business: Ophthalmic Date completed: 4/16/14 Type: Venture financing Raised: $15 million Investors: H.I.G. BioVentures; Morgenthaler Ventures; Versant Ventures; Technology …

    Published on 4/21/2014
  • Galapagos completes warrant exercise

    Galapagos N.V. (Euronext:GLPG; Pink:GLPYY), Mechelen, Belgium Business: Autoimmune, Musculoskeletal, Functional genomics Date completed: 4/10/14 Type: Warrant exercise Raised: 2.4 million ($3.3 million) Shares: 304,791 …

    Published on 4/21/2014
  • Heart Metabolics completes venture financing

    Heart Metabolics Ltd., London, U.K. Business: Cardiovascular Date completed: 4/17/14 Type: Venture financing Raised: Not disclosed Investors: venBio; Seroba Kernel Life Sciences; Brandon Capital Partners; AshHill …

    Published on 4/21/2014
  • Iconic completes venture financing

    Iconic Therapeutics Inc., Atlanta, Ga. Business: Ophthalmic, Cancer Date completed: 4/16/14 Type: Venture financing Raised: $20 million Investors: MPM Capital; Lundbeckfond Ventures; H.I.G. BioVentures Note: The …

    Published on 4/21/2014
  • Knight Therapeutics completes private placement of warrants

    Knight Therapeutics Inc. (TSX-V:GUD), Westmount, Quebec Business: Infectious Date completed: 4/10/14 Type: Private placement of warrants Raised: C$180.1 million ($164.1 million) Shares after offering: 22 million …

    Published on 4/21/2014
  • Lorus completes follow-on

    Lorus Therapeutics Inc. (TSX:LOR; Pink:LRUSF), Toronto, Ontario Business: Cancer, Gene/Cell therapy Date completed: 4/10/14 Type: Follow-on Raised: C$25 million ($22.8 million) Shares: 50 million Price: C$0.50 Shares …

    Published on 4/21/2014
  • Mucosis completes venture financing

    Mucosis B.V., Groningen, the Netherlands Business: Infectious Date completed: 4/15/14 Type: Venture financing Raised: 5 million ($6.9 million) Investors: Changchun BCHT Biotechnology; BioGeneration Ventures; MedSciences…

    Published on 4/21/2014
  • Nexvet completes venture financing

    Nexvet Biopharma, Melbourne, Australia Business: Veterinary Date completed: 4/16/14 Type: Venture financing Raised: $31.5 million Investors: Farallon Capital Management; Adage Capital Partners; Foresite Capital; …

    Published on 4/21/2014
  • Nora Therapeutics completes venture financing

    Nora Therapeutics Inc., Palo Alto, Calif. Business: Genitourinary Date completed: 4/17/14 Type: Venture financing Raised: $18 million Investors: Novo A/S; Burrill; Prospect Venture Partners; Rho Ventures; Vivo Ventures

    Published on 4/21/2014
  • Northwest Biotherapeutics completes direct public offering

    Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md. Business: Cancer Date completed: 4/15/14 Type: Direct public offering Raised: $15 million Shares: 2.3 million Price: $6.60 Shares after offering: 56 million …

    Published on 4/21/2014
  • OxSyBio completes venture financing

    OxSyBio Ltd., London, U.K. Business: Biomanufacturing Date completed: 4/16/14 Type: Venture financing Raised: 500,000 ($836,500) Investor: IP Group Note: The company raised 500,000 ($836,500) in the first tranche of a 1…

    Published on 4/21/2014
  • OxThera completes venture financing

    OxThera AB, Uppsala, Sweden Business: Endocrine/Metabolic Date completed: 4/16/14 Type: Venture financing Raised: SEK70 million ($10.7 million) Investors: Kurma Partners; Idinvest Partners; Mayo Clinic; existing …

    Published on 4/21/2014
  • PanOptica completes venture financing

    PanOptica Inc., Mount Arlington, N.J. Business: Ophthalmic Date completed: 4/15/14 Type: Venture financing Raised: Not disclosed Investors: Novo Ventures; Third Rock Ventures; SV Life Sciences Note: PanOptica raised an …

    Published on 4/21/2014
  • Provista Diagnostics completes venture financing

    Provista Diagnostics Inc., Phoenix, Ariz. Business: Diagnostic Date completed: 4/16/14 Type: Venture financing Raised: $6 million Investors: Existing investors

    Published on 4/21/2014
  • Sorrento completes debt financing

    Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. Business: Cancer, Antibodies Date completed: 4/16/14 Type: Debt financing Raised: $7.5 million Investors: Oxford Finance; Silicon Valley Bank Note: Sorrento …

    Published on 4/21/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993